Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir

A challenge to the treatment of chronic hepatitis C with direct-acting antivirals is the emergence of drug-resistant hepatitis C virus (HCV) variants. HCV with preexisting polymorphisms that are associated with resistance to NS3/4A protease inhibitors have been detected in patients with chronic hepa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Berger, Kristi L., Triki, Ibtissem, Cartier, Mireille, Marquis, Martin, Massariol, Marie-Josée, Böcher, Wulf O., Datsenko, Yakov, Steinmann, Gerhard, Scherer, Joseph, Stern, Jerry O., Kukolj, George
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910880/
https://ncbi.nlm.nih.gov/pubmed/24217701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01976-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados